Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.

Giovam Battista Rini, Maria Stefania Leto Barone, Francesco Castello, Manfredi Rizzo, Gabriele Di Lorenzo, Gaetana Di Fede, Pasquale Mansueto, Nicola Martinelli, Anne Marie Ditto, Maria Luisa Pacor, Claudia Lo Bianco, Vito Ditta

Risultato della ricerca: Articlepeer review

133 Citazioni (Scopus)


Background: To date, no predictive tests for the clinical response to allergen-specific immunotherapy (ASI) are available. Therefore an in vivo or in vitro test would be of great value. Objective: We sought to evaluate pretreatment parameters used in diagnosing allergic rhinitis and determining serum specific IgE (s-IgE) levels, serum total IgE (t-IgE) levels, and blood eosinophil counts and to identify whether can be used to predict clinical improvement in monosensitized patients with allergic rhinitis with or without asthma treated with immunotherapy. Methods: We analyzed 279 patients who had undergone 4 years of ASI administered either by means of the subcutaneous immunotherapy (76 patients) or sublingual immunotherapy (203 patients) routes. Serum t-IgE and s-IgE levels, blood eosinophil counts, and serum s-IgE/t-IgE ratios were calculated and tested for correlation with clinical response to ASI. Receiver operating characteristic curves were determined. Predicted probabilities and predictive areas under the curve were calculated. Results: The clinical response to ASI was effective in 145 (52.0%) of 279 total patients, 42 (55.2%) of 76 patients treated with subcutaneous immunotherapy, and 103 (50.7%) of 203 patients treated with sublingual immunotherapy. A significant correlation was found between the serum s-IgE/t-IgE ratio and the clinical response to ASI, with high ratios (>16.2) associated with an effective response. The sensitivity and specificity of the area under the curve of the ratio were higher than those of serum s-IgE and t-IgE alone. Conclusion: The calculation of the serum s-IgE/t-IgE ratio for predicting the clinical response to ASI offers an advantage over measuring t-IgE and s-IgE levels in monosensitized patients for the following allergens: grass, Parietaria judaica, Olea europea, and house dust mite. © 2009 American Academy of Allergy, Asthma & Immunology.
Lingua originaleEnglish
pagine (da-a)1103-1110
Numero di pagine8
RivistaJournal of Allergy and Clinical Immunology
Stato di pubblicazionePublished - 2009

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2723???
  • ???subjectarea.asjc.2400.2403???


Entra nei temi di ricerca di 'Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.'. Insieme formano una fingerprint unica.

Cita questo